MonticcioloDLNewellMSMoyLLeeCSDestounisSV.Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR. J Am Coll Radiol. 2023;20(9):902-914.
2.
EisenAFletcherGGFienbergS, et al. Breast magnetic resonance imaging for preoperative evaluation of breast cancer: a systematic review and meta-analysis. Can Assoc Radiol J. 2024;75(1):118-135.
3.
GeuzingeHABakkerMFHeijnsdijkEAM, et al. Cost-effectiveness of magnetic resonance imaging screening for women with extremely dense breast tissue. J Natl Cancer Inst. 2021;113(11):1476-1483.
4.
WarnerEZhuSPlewesDB, et al. Breast cancer mortality among women with a BRCA1 or BRCA2 mutation in a magnetic resonance imaging plus mammography screening program. Cancers (Basel). 2020;12(11):3479.
5.
MannRMKuhlCKMoyL.Contrast-enhanced MRI for breast cancer screening. J Magn Reson Imaging. 2019;50(2):377-390.
6.
NiellBLLeeJMJohansenCHalpernEFRaffertyEA.Patient outcomes in canceled MRI-guided breast biopsies. AJR Am J Roentgenol. 2014;202(1):223-228.
7.
Grisaru KacenMBen NachumIShmuilovichOWardCKorneckiA. The role of pre-contrast sequences of an MRI-guided breast biopsy in localizing a target. Can Assoc Radiol J. 2025;76(1):105-112. doi:10.1177/08465371241270511
8.
BrennanSBSungJSDershawDDLibermanLMorrisEA.Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up. Radiology. 2011;261(1):92-99.
9.
ChanJSeelyJLauJ.Does double reading of screening breast MRI scans impact recall rates and cancer detection?Can Assoc Radiol J. 2023;74(2):398-403.
10.
PinkerKMoyLSuttonEJ, et al. Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging. Invest Radiol. 2018;53(10):587-595.
11.
ParekhVSJacobsMA.Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI. NPJ Breast Cancer. 2017;3:43.
